MARCJONATHAN SEROTA: Open Payments
NPI 1740410463 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432,322 in 336 payments from 16 companies in 2025. Trend: 2023 $636,618 · 2024 $672,937 · 2025 $432,322
Speaker / faculty: $348,299Consulting: $41,904Travel & lodging: $23,836Honoraria: $12,800Food & beverage: $5,483
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 67 | $113,353 |
| Lilly USA, LLC | 96 | $91,199 |
| Regeneron Healthcare Solutions, Inc. | 59 | $85,850 |
| UCB, Inc. | 20 | $34,155 |
| Arcutis Biotherapeutics, Inc. | 20 | $26,949 |
| Amgen Inc. | 16 | $17,518 |
| Novartis Pharmaceuticals Corporation | 14 | $16,587 |
| Organon LLC | 9 | $12,904 |
| PFIZER INC. | 7 | $10,173 |
| E.R. Squibb & Sons, L.L.C. | 7 | $9,150 |
Products named: DUPIXENT, EBGLYSS, Bimzelx, Zoryve, OTEZLA, VTAMA, Rhapsido, CIBINQO.
Industry payments across CO — which companies pay providers there.
